Transforming Drug Discovery Through Foundation Models & Generative AI

​Generative AI Drug Discovery & Development Summit at JPM 2026 hosted by BioMap and Legend Capital

​This event brings together leading pharma CEOs, heads of R&D, top academic researchers and life science investors for a productive fireside panel and session to explore the next generation of discovery tools focusing on AI-driven protein de novo design and AI foundation model.

​Discover how cutting-edge AI systems can revolutionize drug discovery by shortening development cycles, enhancing decision-making, and scaling across programs.

​Agenda

• ​4:00 PM – 5:00 PM: Registration

• ​5:00 PM – 5:05 PM: Opening

  • ​Wei Liu, Founder and CEO of BioMap

• ​5:05 PM – 5:25 PM: Keynote 1: From Concept to BIC/FIC: BioMap PoC Case Sharing

  • ​Per Greisen, Chief Computational Biologist

• ​5:25 PM – 6:15 PM: Panel: AI in Drug Discovery: Opportunities & Challenge

  • ​OrbiMed, Millennium, Deerfield, Thermo Fisher, and Propeller Bio

• ​6:15 PM – 6:30 PM: Break

• ​6:30 PM – 6:55 PM: Keynote 2: BioMap AI-Enabled Wet/Dry Loop System – Journey to the Virtual Cell Global Championship

  • ​Ziyao Xu, Head of Strategy and Innovation

  • ​Xiaoming Zhang, Head of R&D

• ​6:55 PM – 7:35 PM: Panel: Partner Insights & Vision: Leveraging AI to Elevate R&D Efficiency

  • ​Legend, Ribo, Sciwind, Exegenesis, Accuedit

• ​7:35 PM – 7:55 PM: Keynote 3: Empowering Drug Discovery and Global Connectivity

  • ​Joshua Chang, Senior Director, HKIC

• ​7:55 PM – 9:30 PM: Networking Event

​This is a unique opportunity to connect with forward-thinking executives dedicated to pioneering innovation in biotech and pharma.

​Please note, this event is exclusively for executive leaders—not for sales/marketing representatives of service providers or similar organizations.